Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of midazolam for 24-hour continuous sedation after cesarean section in women with preeclampsia
ChiCTR2500114682Phase 4Not yet recruiting
- Sponsor
- Zhuji People's Hospital of Zhejiang Province
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of midazolam in preeclampsia (4 arms), sponsored by Zhuji People's Hospital of Zhejiang Province. Primary endpoint: Blood oxygen saturation (SPO2), mean arterial pressure (MAP), heart rate (HR). Planned start Dec 2025; status: not yet recruiting.
02
Drugs
midazolam
03
Conditions
preeclampsia
Beyond the preview
Go deeper on ChiCTR2500114682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114682.